Clinipace,
a global full-service contract research organization (CRO), will
showcase Clarity
Stack® clinical technology at the 2019 Drug Information Association
(DIA) Annual Meeting. Clarity Stack is an innovative clinical and study
data aggregation solution that provides an up-to-date perspective of
trial progress with visual insights and a holistic view of study-related
information.
“Most sponsors are using some level of eClinical technology to access
data and make decisions on study progress and patient safety,” said Jason
Monteleone, MBA, Clinipace CEO. “But those solutions often operate
in silos. Clarity Stack integrates individual and cross trial data which
supports dynamic decision-making with near-real-time information.”
A suite of specialized tools provides efficient data interoperability to
support regulatory compliance, protect patient safety, and ease the
burden of time-consuming, manual review of disparate data.
“With the ever-increasing cost of clinical trials, we need to put key
information into the hands of researchers fast so that fully informed,
critical decisions can be made quickly,” said Charlene
Dark, senior vice president, global clinical analytics. “Our Clarity
Stack platform provides researchers data and insights to expedite
decisions anytime, anywhere — even from a mobile device.”
To support the technology’s growth, Clinipace has added Mark
Gorton, vice president of IT and innovation, to its team. With more
than 30 years of industry experience in data and analytics, Gorton will
lead the further development of Clarity Stack technologies to support
more cost-effective trials and better patient outcomes.
Clinipace will be conducting demonstrations of Clarity Stack technology
in Booth 1605 at DIA,
June 24–26, 2019.
About Clinipace
At Clinipace,
a global, full-service contract research organization (CRO), our
approach to clinical research is personal. We deliver a level of
collaboration and flexibility not possible in a traditional CRO
environment. With personalized services and solutions, local regulatory
expertise and therapeutic leadership, we overcome the most difficult
industry challenges across all major therapeutic areas including
oncology, gastroenterology, nephrology and urology, rare disease, and
women’s health. We strive to improve the way clinical research is
performed and impact the future of health care using the most advanced
technology and a CHALLENGE ACCEPTED approach.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190620005100/en/